A citation-based method for searching scientific literature

Glenn F King. Expert Opin Biol Ther 2011
Times Cited: 322







List of co-cited articles
972 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Peptide therapeutics from venom: Current status and potential.
Michael W Pennington, Andrzej Czerwinski, Raymond S Norton. Bioorg Med Chem 2018
131
23

Therapeutic potential of venom peptides.
Richard J Lewis, Maria L Garcia. Nat Rev Drug Discov 2003
497
22

Complex cocktails: the evolutionary novelty of venoms.
Nicholas R Casewell, Wolfgang Wüster, Freek J Vonk, Robert A Harrison, Bryan G Fry. Trends Ecol Evol 2013
456
15

Venomics: a new paradigm for natural products-based drug discovery.
Irina Vetter, Jasmine L Davis, Lachlan D Rash, Raveendra Anangi, Mehdi Mobli, Paul F Alewood, Richard J Lewis, Glenn F King. Amino Acids 2011
133
13

Toxins and drug discovery.
Alan L Harvey. Toxicon 2014
114
13


Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
Samuel D Robinson, Eivind A B Undheim, Beatrix Ueberheide, Glenn F King. Expert Rev Proteomics 2017
56
21

Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.
Irène R Chassagnon, Claudia A McCarthy, Yanni K-Y Chin, Sandy S Pineda, Angelo Keramidas, Mehdi Mobli, Vi Pham, T Michael De Silva, Joseph W Lynch, Robert E Widdop,[...]. Proc Natl Acad Sci U S A 2017
105
11

The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms.
Bryan G Fry, Kim Roelants, Donald E Champagne, Holger Scheib, Joel D A Tyndall, Glenn F King, Timo J Nevalainen, Janette A Norman, Richard J Lewis, Raymond S Norton,[...]. Annu Rev Genomics Hum Genet 2009
491
11

Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain.
Jeremiah D Osteen, Volker Herzig, John Gilchrist, Joshua J Emrick, Chuchu Zhang, Xidao Wang, Joel Castro, Sonia Garcia-Caraballo, Luke Grundy, Grigori Y Rychkov,[...]. Nature 2016
177
11

Conus venom peptide pharmacology.
Richard J Lewis, Sébastien Dutertre, Irina Vetter, MacDonald J Christie. Pharmacol Rev 2012
278
10

Spider-venom peptides as therapeutics.
Natalie J Saez, Sebastian Senff, Jonas E Jensen, Sing Yan Er, Volker Herzig, Lachlan D Rash, Glenn F King. Toxins (Basel) 2010
187
9

Specialized insulin is used for chemical warfare by fish-hunting cone snails.
Helena Safavi-Hemami, Joanna Gajewiak, Santhosh Karanth, Samuel D Robinson, Beatrix Ueberheide, Adam D Douglass, Amnon Schlegel, Julita S Imperial, Maren Watkins, Pradip K Bandyopadhyay,[...]. Proc Natl Acad Sci U S A 2015
86
10


Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial.
Eric J Tarcha, Chelsea M Olsen, Peter Probst, David Peckham, Ernesto J Muñoz-Elías, James G Kruger, Shawn P Iadonato. PLoS One 2017
72
12

From snake venom toxins to therapeutics--cardiovascular examples.
Cho Yeow Koh, R Manjunatha Kini. Toxicon 2012
130
9


Epidemiology of scorpionism: a global appraisal.
J-P Chippaux, M Goyffon. Acta Trop 2008
327
8


Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails.
Sébastien Dutertre, Ai-Hua Jin, Irina Vetter, Brett Hamilton, Kartik Sunagar, Vincent Lavergne, Valentin Dutertre, Bryan G Fry, Agostinho Antunes, Deon J Venter,[...]. Nat Commun 2014
177
8

Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.
Shilong Yang, Yao Xiao, Di Kang, Jie Liu, Yuan Li, Eivind A B Undheim, Julie K Klint, Mingqiang Rong, Ren Lai, Glenn F King. Proc Natl Acad Sci U S A 2013
120
8

Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
Julie K Klint, Sebastian Senff, Darshani B Rupasinghe, Sing Yan Er, Volker Herzig, Graham M Nicholson, Glenn F King. Toxicon 2012
155
8

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Justin K Murray, Joseph Ligutti, Dong Liu, Anruo Zou, Leszek Poppe, Hongyan Li, Kristin L Andrews, Bryan D Moyer, Stefan I McDonough, Philippe Favreau,[...]. J Med Chem 2015
91
8

Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.
Julie K Klint, Sebastian Senff, Natalie J Saez, Radha Seshadri, Ho Yee Lau, Niraj S Bende, Eivind A B Undheim, Lachlan D Rash, Mehdi Mobli, Glenn F King. PLoS One 2013
107
8

Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
Hui Xu, Tianbo Li, Alexis Rohou, Christopher P Arthur, Foteini Tzakoniati, Evera Wong, Alberto Estevez, Christine Kugel, Yvonne Franke, Jun Chen,[...]. Cell 2019
69
11

Snake venomics. Strategy and applications.
Juan J Calvete, Paula Juárez, Libia Sanz. J Mass Spectrom 2007
245
7

Conus venoms: a rich source of novel ion channel-targeted peptides.
Heinrich Terlau, Baldomero M Olivera. Physiol Rev 2004
665
7



From foe to friend: using animal toxins to investigate ion channel function.
Jeet Kalia, Mirela Milescu, Juan Salvatierra, Jordan Wagner, Julie K Klint, Glenn F King, Baldomero M Olivera, Frank Bosmans. J Mol Biol 2015
108
7

Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins.
Huaizong Shen, Dongliang Liu, Kun Wu, Jianlin Lei, Nieng Yan. Science 2019
175
7

The engineering of an orally active conotoxin for the treatment of neuropathic pain.
Richard J Clark, Jonas Jensen, Simon T Nevin, Brid P Callaghan, David J Adams, David J Craik. Angew Chem Int Ed Engl 2010
213
7

The Diversity of Venom: The Importance of Behavior and Venom System Morphology in Understanding Its Ecology and Evolution.
Vanessa Schendel, Lachlan D Rash, Ronald A Jenner, Eivind A B Undheim. Toxins (Basel) 2019
62
11

Scorpion venom components as potential candidates for drug development.
Ernesto Ortiz, Georgina B Gurrola, Elisabeth Ferroni Schwartz, Lourival D Possani. Toxicon 2015
165
7


Venoms, venomics, antivenomics.
Juan J Calvete, Libia Sanz, Yamileth Angulo, Bruno Lomonte, José María Gutiérrez. FEBS Lett 2009
240
6

The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system.
Freek J Vonk, Nicholas R Casewell, Christiaan V Henkel, Alysha M Heimberg, Hans J Jansen, Ryan J R McCleary, Harald M E Kerkkamp, Rutger A Vos, Isabel Guerreiro, Juan J Calvete,[...]. Proc Natl Acad Sci U S A 2013
300
6


Venomics as a drug discovery platform.
Pierre Escoubas, Glenn F King. Expert Rev Proteomics 2009
112
6

The future of peptide-based drugs.
David J Craik, David P Fairlie, Spiros Liras, David Price. Chem Biol Drug Des 2013
962
6

Deep venomics reveals the mechanism for expanded peptide diversity in cone snail venom.
Sébastien Dutertre, Ai-hua Jin, Quentin Kaas, Alun Jones, Paul F Alewood, Richard J Lewis. Mol Cell Proteomics 2013
139
6

Why do we study animal toxins?
Yun Zhang. Dongwuxue Yanjiu 2015
63
9

Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a.
Jennifer R Deuis, Zoltan Dekan, Joshua S Wingerd, Jennifer J Smith, Nehan R Munasinghe, Rebecca F Bhola, Wendy L Imlach, Volker Herzig, David A Armstrong, K Johan Rosengren,[...]. Sci Rep 2017
90
6

A rational nomenclature for naming peptide toxins from spiders and other venomous animals.
Glenn F King, Margaret C Gentz, Pierre Escoubas, Graham M Nicholson. Toxicon 2008
204
6

SignalP 4.0: discriminating signal peptides from transmembrane regions.
Thomas Nordahl Petersen, Søren Brunak, Gunnar von Heijne, Henrik Nielsen. Nat Methods 2011
6


Multifaceted roles of disulfide bonds. Peptides as therapeutics.
Miriam Góngora-Benítez, Judit Tulla-Puche, Fernando Albericio. Chem Rev 2014
252
6


Voltage-gated ion channels and gating modifier toxins.
William A Catterall, Sandrine Cestèle, Vladimir Yarov-Yarovoy, Frank H Yu, Keiichi Konoki, Todd Scheuer. Toxicon 2007
420
6

Antibodies and venom peptides: new modalities for ion channels.
Heike Wulff, Palle Christophersen, Paul Colussi, K George Chandy, Vladimir Yarov-Yarovoy. Nat Rev Drug Discov 2019
60
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.